EUR 15.88
(-0.75%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 276.25 Million EUR | 38.62% |
2022 | 202.57 Million EUR | -0.24% |
2021 | 203.05 Million EUR | -16.31% |
2020 | 242.62 Million EUR | 14.21% |
2019 | 212.44 Million EUR | -2.61% |
2018 | 218.12 Million EUR | -19.53% |
2017 | 271.07 Million EUR | 2.45% |
2016 | 264.6 Million EUR | 9.17% |
2015 | 242.37 Million EUR | 11.5% |
2014 | 217.37 Million EUR | 2.1% |
2013 | 212.9 Million EUR | -23.75% |
2012 | 279.2 Million EUR | 27.45% |
2011 | 219.07 Million EUR | 8.97% |
2010 | 201.03 Million EUR | -9.57% |
2009 | 222.31 Million EUR | 14.13% |
2008 | 194.79 Million EUR | -5.78% |
2007 | 206.74 Million EUR | -17.55% |
2006 | 250.74 Million EUR | 1.47% |
2005 | 247.11 Million EUR | 25.09% |
2004 | 197.55 Million EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | 73.27 Million EUR | -10.3% |
2024 Q1 | 81.67 Million EUR | -39.71% |
2023 Q1 | 68.92 Million EUR | -35.38% |
2023 Q4 | 135.47 Million EUR | 114.03% |
2023 FY | 280.79 Million EUR | 38.62% |
2023 Q3 | 63.29 Million EUR | -56.31% |
2023 Q2 | 144.88 Million EUR | 110.2% |
2022 Q2 | 118.57 Million EUR | 0.0% |
2022 FY | 202.57 Million EUR | -0.24% |
2022 Q4 | 106.66 Million EUR | 0.0% |
2021 Q3 | 52.34 Million EUR | -54.2% |
2021 FY | 203.05 Million EUR | -16.31% |
2021 Q1 | 52.34 Million EUR | -41.71% |
2021 Q2 | 114.27 Million EUR | 118.32% |
2021 Q4 | 103.11 Million EUR | 96.99% |
2020 Q2 | 168.66 Million EUR | 163.24% |
2020 FY | 242.62 Million EUR | 14.21% |
2020 Q4 | 89.8 Million EUR | 40.15% |
2020 Q1 | 64.07 Million EUR | -46.03% |
2020 Q3 | 64.07 Million EUR | -62.01% |
2019 Q4 | 118.71 Million EUR | 105.55% |
2019 FY | 212.44 Million EUR | -2.61% |
2019 Q2 | 107.15 Million EUR | 85.54% |
2019 Q1 | 57.75 Million EUR | 3.82% |
2019 Q3 | 57.75 Million EUR | -46.1% |
2018 Q3 | 55.62 Million EUR | 0.0% |
2018 FY | 218.12 Million EUR | -19.53% |
2018 Q1 | 55.62 Million EUR | -20.7% |
2018 Q2 | 55.62 Million EUR | 0.0% |
2018 Q4 | 55.62 Million EUR | 0.0% |
2017 Q4 | 70.14 Million EUR | 0.0% |
2017 FY | 271.07 Million EUR | 2.45% |
2017 Q2 | 70.14 Million EUR | 0.0% |
2017 Q1 | 70.14 Million EUR | 6.39% |
2017 Q3 | 70.14 Million EUR | 0.0% |
2016 Q1 | 65.93 Million EUR | 6.77% |
2016 Q4 | 65.93 Million EUR | 0.0% |
2016 Q3 | 65.93 Million EUR | 0.0% |
2016 Q2 | 65.93 Million EUR | 0.0% |
2016 FY | 264.6 Million EUR | 9.17% |
2015 Q1 | 61.75 Million EUR | 7.98% |
2015 Q4 | 61.75 Million EUR | 0.0% |
2015 Q3 | 61.75 Million EUR | 0.0% |
2015 Q2 | 61.75 Million EUR | 0.0% |
2015 FY | 242.37 Million EUR | 11.5% |
2014 Q3 | 57.18 Million EUR | 0.0% |
2014 FY | 217.37 Million EUR | 2.1% |
2014 Q4 | 57.18 Million EUR | 0.0% |
2014 Q2 | 57.18 Million EUR | 0.0% |
2014 Q1 | 57.18 Million EUR | 0.53% |
2013 FY | 212.9 Million EUR | -23.75% |
2013 Q3 | 56.89 Million EUR | 0.0% |
2013 Q4 | 56.89 Million EUR | 0.0% |
2013 Q2 | 56.89 Million EUR | 0.0% |
2013 Q1 | 56.89 Million EUR | -8.14% |
2012 Q1 | 61.93 Million EUR | 13.08% |
2012 Q3 | 61.93 Million EUR | 0.0% |
2012 FY | 279.2 Million EUR | 27.45% |
2012 Q2 | 61.93 Million EUR | 0.0% |
2012 Q4 | 61.93 Million EUR | 0.0% |
2011 FY | 219.07 Million EUR | 8.97% |
2011 Q2 | 54.76 Million EUR | 0.0% |
2011 Q1 | 54.76 Million EUR | 8.97% |
2011 Q4 | 54.76 Million EUR | 0.0% |
2011 Q3 | 54.76 Million EUR | 0.0% |
2010 Q2 | 50.25 Million EUR | 0.0% |
2010 Q4 | 50.25 Million EUR | 0.0% |
2010 FY | 201.03 Million EUR | -9.57% |
2010 Q1 | 50.25 Million EUR | -9.57% |
2010 Q3 | 50.25 Million EUR | 0.0% |
2009 Q4 | 55.57 Million EUR | 0.0% |
2009 Q3 | 55.57 Million EUR | 0.0% |
2009 Q2 | 55.57 Million EUR | 0.0% |
2009 Q1 | 55.57 Million EUR | 14.13% |
2009 FY | 222.31 Million EUR | 14.13% |
2008 Q3 | 48.69 Million EUR | 0.0% |
2008 FY | 194.79 Million EUR | -5.78% |
2008 Q2 | 48.69 Million EUR | 0.0% |
2008 Q1 | 48.69 Million EUR | -5.78% |
2008 Q4 | 48.69 Million EUR | 0.0% |
2007 Q2 | 51.68 Million EUR | 0.0% |
2007 Q3 | 51.68 Million EUR | 0.0% |
2007 FY | 206.74 Million EUR | -17.55% |
2007 Q4 | 51.68 Million EUR | 0.0% |
2007 Q1 | 51.68 Million EUR | 11.84% |
2006 Q2 | 46.21 Million EUR | 0.0% |
2006 Q3 | 46.21 Million EUR | 0.0% |
2006 Q4 | 46.21 Million EUR | 0.0% |
2006 Q1 | 46.21 Million EUR | -0.1% |
2006 FY | 250.74 Million EUR | 1.47% |
2005 Q1 | 46.26 Million EUR | 28.22% |
2005 Q4 | 46.26 Million EUR | 0.0% |
2005 Q3 | 46.26 Million EUR | 0.0% |
2005 FY | 247.11 Million EUR | 25.09% |
2005 Q2 | 46.26 Million EUR | 0.0% |
2004 Q4 | 36.07 Million EUR | 0.0% |
2004 Q1 | 36.07 Million EUR | 0.0% |
2004 FY | 197.55 Million EUR | 0.0% |
2004 Q3 | 36.07 Million EUR | 0.0% |
2004 Q2 | 36.07 Million EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Naturhouse Health, S.A. | 16.26 Million EUR | -1598.543% |
Deoleo, S.A. | -7.32 Million EUR | 3869.801% |